Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caribou Biosciences Inc
(NQ:
CRBU
)
2.090
+0.010 (+0.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Caribou Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Caribou Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
August 14, 2024
Via
Benzinga
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
August 12, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Evaluating Caribou Biosciences: Insights From 4 Financial Analysts
July 17, 2024
Via
Benzinga
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
July 09, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
June 04, 2024
Via
Benzinga
Expert Ratings For Caribou Biosciences
May 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 03, 2024
Via
Benzinga
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 30, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Attention Biotech Investors - Stocks To Watch
May 16, 2024
RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences,...
Via
Benzinga
3 Underappreciated Stocks That Could 10x in 10 Years
May 12, 2024
10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line.
Via
InvestorPlace
CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
CRBU stock results show that Caribou Biosciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 01, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
April 15, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
April 05, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
April 04, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points
March 13, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index remained in the "Greed" zone on Tuesday.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Gold Down Over 1%; ClearOne Shares Spike Higher
March 12, 2024
U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on Tuesday. The Dow traded up 0.74% to 39,057.10 while the NASDAQ rose 1.41% to 16,245.83. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 12, 2024
Via
Benzinga
Why Caribou Biosciences Stock Is Crashing Today
March 12, 2024
Investors didn't like the clinical-stage biotech's Q4 update for one key reason.
Via
The Motley Fool
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 11, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
February 26, 2024
Buy this stock if you're daring, but avoid it for now if you aren't.
Via
The Motley Fool
Caribou Biosciences to Participate in Upcoming Investor Conferences
February 15, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.